Orchestra BioMed Holdings Inc — 四半期キャッシュフロー (NASDAQ:OBIO) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 76.17 M59.05 M42.83 M104.81 M114.86 M 負債合計 43.22 M42.19 M42.53 M61.07 M51.48 M 純資産合計 32.96 M16.86 M295 K43.74 M53.57 M 負債および純資産合計 76.17 M59.05 M42.83 M104.81 M114.86 M 有利子負債合計 14.29 M14.34 M14.38 M14.2 M14.27 M 純負債 -52.52 M-35.55 M-19.54 M-81.62 M-92.24 M

ニュース

Chardan、Orchestra BioMed株の投資判断を維持、臨床試験に注目

Chardan reiterates Orchestra BioMed stock rating on trial focus

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Orchestra BioMed to present hypertension therapy data at medical meetings

TD CowenがOrchestra BioMed株を新規の医療機器ポートフォリオでBuy評価開始

TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

メドトロニック、尿失禁治療デバイスでFDA承認を取得

パイパー・サンドラー、DexComの「オーバーウェイト」評価を再確認